Dermatologic Emergencies

dermatology-emergencieskapak-1-0-25

Cutaneous Dermatophytes/Tinea

Sedat ÖZBAY
Sivas Numune Hospital, Clinic of Emergencies Medicine, Sivas, Türkiye

Mustafa AYAN
Sivas Numune Hospital, Clinic of Emergencies Medicine, Sivas, Türkiye

Özbay S, Ayan M. Cutaneous dermatophytes/tinea. In: Oğuztürk H, Görmeli Kurt N, eds. Dermatologic Emergencies. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.164-70.

ABSTRACT

Dermatophyte infections are caused by fungi species like Trichophyton, Epidermophyton and Microsporum that adhere to the stratum corneum which the outermost layer of epidermis, and the age of detection varies depending On the area of the body where they are detected. The general initial symptom is itching. It is transmitted through contact with humans, animals and soil. Histopathology, culture and examination are important in confiming the diagnosis. Treatment includes topical and oral antifungals as well as some precautions.

Keywords: Dermatophyte; tinea pedis; tinea capitis; tinea cruris; pruritus

Referanslar

  1. Prawer S, Bershow A, Prawer S. Superficial Fungal Infections. In: Soutor C, Hardinsky MK, eds. Clinical Dermatology LANGE. 1st ed. Mc Graw Hill Education; 2013. p.71-87. [Link]
  2. Al Aboud AM, Crane JS. Tinea Capitis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  3. Shemer A, Gupta AK, Amichai B, Baum S, Barzilai A, Farhi R, et al. Increased Risk of Tinea Pedis and Onychomycosis Among Swimming Pool Employees in Netanya Area, Israel. Mycopathologia. 2016;181(11-12):851-6. [Crossref]  [PubMed]
  4. Mazza M, Refojo N, Davel G, Lima N, Dias N, Da Silva CMFP et al. Epidemiology of dermatophytoses in 31 municipalities of the province of Buenos Aires, Argentina: A 6-year study. Rev Iberoam Micol. 2018;35(2):97-102. [Crossref]  [PubMed]
  5. Taplin D. Dermatophytosis in Vietnam. Cutis. 2001;67(5 Suppl):19-20. [PubMed]
  6. Zhan P, Geng C, Li Z, Jiang Q, Jin Y, Li C, Liu W. The epidemiology of tinea manuum in Nanchang area, South China. Mycopathologia. 2013;176(1-2):83-8. [Crossref]  [PubMed]
  7. Chamorro MJ, Syed HA, House SA. Tinea Manuum. [Updated 2024 Mar 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  8. Duarte B, Galhardas C, Cabete J. Adult tinea capitis and tinea barbae in a tertiary Portuguese hospital: A 11-year audit. Mycoses. 2019;62(11):1079-83. [Crossref]  [PubMed]
  9. Rodríguez-Cerdeira C, Martínez-Herrera E, Szepietowski JC, Pinto-Almazán R, Frías-De-León MG, Espinosa-Hernández VM, et al. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol. 2021;35(4):844-83. [Crossref]  [PubMed]
  10. Walsh AL, Merchan N, Harper CM. Hedgehog-Transmitted Trichophyton erinaceid Causing Painful Bullous Tinea Manuum. J Hand Surg Am. 2021;46(5):430.e1-430.e3. [Crossref]  [PubMed]
  11. Veraldi S, Schianchi R, Benzecry V, Gorani A. Tinea manuum: A report of 18 cases observed in the metropolitan area of Milan and review of the literature. Mycoses. 2019;62(7):604-8. [Crossref]  [PubMed]
  12. Nigam PK, Syed HA, Saleh D. Tinea Pedis. [Updated 2023 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  13. Moseley I, Ragi SD, Ouellette S, Rao B. Tinea pedis in underrepresented groups: All of Us database analysis. Mycoses. 2023;66(1):29-34. [Crossref]  [PubMed]
  14. Ogawa T, Matsuda A, Ogawa Y, Tanaka R. Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan. J Dermatol. 2024;51(1):30-9. [Crossref]  [PubMed]  [PMC]
  15. Ongsri P, Bunyaratavej S, Leeyaphan C, Pattanaprichakul P, Ongmahutmongkol P, Komoltri C, Kulthanan K. Prevalence and Clinical Correlation of Superficial Fungal Foot Infection in Thai Naval Rating Cadets. Mil Med. 2018;183(9-10):e633-e7. [Crossref]  [PubMed]
  16. Wang R, Song Y, Du M, Yang E, Yu J, Wan Z, Li R. Skin microbiome changes in patients with interdigital tinea pedis. Br J Dermatol. 2018;179(4):965-8. [Crossref]  [PubMed]
  17. Appelt L, Nenoff P, Uhrlaß S, Krüger C, Kühn P, Eichhorn K, et al. Terbinafinresistente Dermatophytosen und Onychomykose durch Trichophyton rubrum [Terbinafine-resistant dermatophytoses and onychomycosis due to Trichophyton rubrum]. Hautarzt. 2021;72(10):868-77. German. [Crossref]  [PubMed]
  18. Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. 2002;47(2):286- 90. [Crossref]  [PubMed]
  19. Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77-86. [Crossref]  [PubMed]  [PMC]
  20. Pippin MM, Madden ML, Das M. Tinea Cruris. [Updated 2023 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: [Link]
  21. Goldfarb N, Lin SW. Skin diseases of the Face. In: Soutor C, Hardinsky MK, eds. Clinical Dermatology Lange. 1st ed. Mc Graw Hill Education; 2013. p.268- 79. [Link]
  22. Lipner SR, Scher RK. Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835-51. [Crossref]  [PubMed]
  23. Arsenijević VA, Denning DW. Estimated Burden of Serious Fungal Diseases in Serbia. J Fungi (Basel). 2018;4(3):76. [Crossref]  [PubMed]  [PMC]
  24. Yee G, Al Aboud AM. Tinea Corporis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  25. Souissi A, Ben Lagha I, Toukabri N, Mama M, Mokni M. Morse code-like hairs in tinea capitis disappear after successful treatment. Int J Dermatol. 2018;57(12):e150-e1. [Crossref]  [PubMed]
  26. Julapalli MR, Levy ML. Viral and Fungal Skin Infections. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, eds. Feigin & Cherry's Text book of Pediatric Infectious Diseases. 6th ed. Philadelphia: Saunders Elsevier; 2009. p.794-809. [Crossref]
  27. Hay RJ. Tinea Capitis: Current Status. Mycopathologia. 2017;182(1-2):87- 93. [Crossref]  [PubMed]  [PMC]
  28. Degreef H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia. 2008;166(5-6):257-65. [Crossref]  [PubMed]
  29. James WD, Berger TG, Elston DM. Diseases Resulting from Fungi and Yeasts. James WD' Diseases of the Skin Clinical Dermatology. 12th ed. Elsevier; 2016. p.285-318. [Link]
  30. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol Clin. 2003;21(3): 491-7, vii. [Crossref]  [PubMed]
  31. Levitt JO, Levitt BH, Akhavan A, Yanofsky H. The sensitivity and specificity of potassium hydroxide smear and fungal culture relative to clinical assessment in the evaluation of tinea pedis: a pooled analysis. Dermatol Res Pract. 2010;2010:764843. [Crossref]  [PubMed]  [PMC]
  32. Gupta AK, Hall DC, Cooper EA, Ghannoum MA. Diagnosing Onychomycosis: What's New? J Fungi (Basel). 2022;8(5):464. [Crossref]  [PubMed]  [PMC]
  33. Jakhar D, Kaur I, Sonthalia S. Dermoscopy of Tinea Manuum. Indian Dermatol Online J. 2019;10(2):210-1. [Crossref]  [PubMed]  [PMC]
  34. Thakur R, Kalsi AS. Outbreaks And Epidemics Of Superficial Dermatophytosis Due To Trichophyton mentagrophytes Complex And Microsporum canis: Global And Indian Scenario. Clin Cosmet Investig Dermatol. 2019;12:887-93. [PubMed]  [PMC]
  35. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003;67(1):101-8. [Link]
  36. Chen X, Jiang X, Yang M, González U, Lin X, Hua X, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016;2016(5):CD004685. [Crossref]  [PubMed]
  37. Chen C, Koch LH, Dice JE, Dempsey KK, Moskowitz AB, BarnesEley ML, et al. A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. Pediatr Dermatol. 2010;27(5):459-62. [Crossref]  [PubMed]
  38. Khurana A, Agarwal A, Agrawal D, Panesar S, Ghadlinge M, Sardana K, et al. Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial. JAMA Dermatol. 2022;158(11):1269-78. [Crossref]  [PubMed]  [PMC]
  39. van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol. 2015;172(3):616-41. [Crossref]  [PubMed]
  40. Bell-Syer SE, Hart R, Crawford F, Torgerson DJ, Tyrrell W, Russell I. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev. 2002;(2):CD003584. [Crossref]  [PubMed]
  41. Schaller M, Friedrich M, Papini M, Pujol RM, Veraldi S. Topical antifungalcorticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting. Mycoses. 2016;59(6):365-73. [Crossref]  [PubMed]
  42. Kreijkamp-Kaspers S, Hawke K, Guo L, Kerin G, Bell-Syer SE, Magin P, et al. Oral antifungal medication for toenail onychomycosis. Cochrane Database Syst Rev. 2017;7(7):CD010031. [Crossref]  [PubMed]  [PMC]
  43. Elewski BE, Cáceres HW, DeLeon L, El Shimy S, Hunter JA, Korotkiy N, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol. 2008;59(1):41-54. [Crossref]  [PubMed]
  44. Kimberlin DW, Brady MT, Jackson MA, Long SS. Tinea capitis. Red Book: Report of the Committee on Infectious Diseases. 30th ed. American Academy of Pediatrics. 2015. p.778. [Link]